The decision applies to adolescents and adults and aligns with earlier US authorization for higher-risk groups.
An expert panel of the EU drug regulator, the European Medicines Agency (EMA), endorsed seven new medicines for approval this ...
Preliminary analysis showed the 2025-2026 formula of mNEXSPIKE generated greater than a 16-fold increase in LP.8.1-neutralizing antibodies across age groups Both of Moderna’s COVID-19 vaccines for the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback